ACTRN12614000622606
Not yet recruiting
Phase 1
In a patient with chronic ischaemic chest pain, will Sativex Oromucosal Spray reduce their pain
Dr Adrian Owen0 sites10 target enrollmentJune 11, 2014
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr Adrian Owen
- Enrollment
- 10
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •In this initial trial the treatment group will be patients admitted to Waikato Hospital Emergency Department or Cardiology department, who are known to suffer from intractable coronary disease
Exclusion Criteria
- •–Hypersensitivity to cannabinoids
- •–History of Schizophrenia
- •–Pregnant or breast feeding mothers
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of intensive risk factor modification in patients referred to a public clinic with chest pain.ACTRN12617000615381Royal Hobart Hospital221
Recruiting
Not Applicable
Cohort Study for Patients with Acute Chest PaiJPRN-UMIN000054014Japanese Red Cross Wakayama Medical Center500
Recruiting
Not Applicable
Impact of Exercise Training on Ischemia With Non-Obstructive Coronary Arteries (INOCA): The ExINOCA StudyCoronary Microvascular DiseaseCMDNCT06529848Bispebjerg Hospital100
Recruiting
Not Applicable
Non-invasive Diagnosis of Coronary Microvascular Disease: Pilot StudyMicrovascular AnginaNCT06070662University of Leicester20
Completed
Not Applicable
Screening Non-cardiac population in cardiology departmentHealth Condition 1: J98- Other respiratory disordersCTRI/2023/02/049735Manipal Academy Higher Education100